Section of Microbiology and Applied Pathology, University of Ferrara, Ferrara, Italy.
Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Front Immunol. 2022 Jun 17;13:904419. doi: 10.3389/fimmu.2022.904419. eCollection 2022.
A long-shared evolutionary history is congruent with the multiple roles played by purinergic signaling in viral infection, replication and host responses that can assist or hinder viral functions. An overview of the involvement of purinergic signaling among a range of viruses is compared and contrasted with what is currently understood for SARS-CoV-2. In particular, we focus on the inflammatory and antiviral responses of infected cells mediated by purinergic receptor activation. Although there is considerable variation in a patient's response to SARS-CoV-2 infection, a principle immediate concern in Coronavirus disease (COVID-19) is the possibility of an aberrant inflammatory activation causing diffuse lung oedema and respiratory failure. We discuss the most promising potential interventions modulating purinergic signaling that may attenuate the more serious repercussions of SARS-CoV-2 infection and aspects of their implementation.
嘌呤能信号在病毒感染、复制和宿主反应中发挥多种作用,这与嘌呤能信号的长期共同进化史是一致的,这些作用可以辅助或阻碍病毒功能。本文比较和对比了嘌呤能信号在一系列病毒中的作用,概述了目前对 SARS-CoV-2 的了解。特别是,我们专注于嘌呤能受体激活介导的受感染细胞的炎症和抗病毒反应。尽管患者对 SARS-CoV-2 感染的反应存在相当大的差异,但在冠状病毒病 (COVID-19) 中,一个主要的直接关注点是异常炎症激活导致弥漫性肺水肿和呼吸衰竭的可能性。我们讨论了最有希望的潜在干预措施,即调节嘌呤能信号,可能减轻 SARS-CoV-2 感染更严重的后果,以及它们实施的一些方面。